News und Analysen
Lyra Therapeutics Posts 85% Q2 Loss Drop
Lyra Therapeutics (NASDAQ:LYRA), a clinical-stage biotechnology company focused on chronic rhinosinusitis (CRS) treatments, reported its second quarter 2025 results on August 12, 2025. The most
Iridex Reports 7 Percent Q2 Revenue Gain
Iridex (NASDAQ:IRIX), a medical device company specializing in laser-based systems for eye disease treatments, reported its second quarter results on August 12, 2025, covering the three months ended
Webtoon Reports 8 Percent Revenue Gain
Webtoon Entertainment (NASDAQ:WBTN), a global digital comics publisher and platform operator, reported results on August 12, 2025. Revenue (GAAP) reached $348.3 million, coming in $7.7 million above
Vicarious Surgical Narrows Loss in Q2
Vicarious Surgical (NYSE:RBOT), a developer focused on next-generation robotic technology for minimally invasive surgery, released its second quarter 2025 financial results on August 12, 2025. The
Verrica Posts Profit in Fiscal Q2
Verrica Pharmaceuticals (NASDAQ:VRCA), a specialty dermatology company focused on skin disease treatments, released its earnings for the second quarter of fiscal 2025 on August 12, 2025. The
Luminar Posts 5 Percent Sales Drop
Luminar Technologies (NASDAQ:LAZR), a leading developer of laser-based sensors and software for advanced driver-assistance systems and autonomous vehicles, reported results for Q2 2025 on August 12
Nexgel Revenue Jumps 100% in Fiscal Q2
Nexgel (NASDAQ:NXGL), a maker of hydrogel-based wound care and beauty products, released its second quarter results for fiscal 2025 on August 12, 2025. The key news from the release was strong
Fractyl Health Posts 62% Wider Q2 Loss
Fractyl Health (NASDAQ:GUTS), a clinical-stage biotech developing interventions for obesity and Type 2 Diabetes (T2D), reported its second quarter 2025 results on August 12, 2025. The period was
Cameco Corporation Stock Continues to Climb. But Is the Growth Path Sustainable?
Cameco's (NYSE: CCJ) share price has roughly doubled in value over the past year. Much of that gain has taken place since a rally started in April. Can Cameco's shares continue to rocket higher, or
CXApp Grows ARR and Margins in Q2 2025
CXApp(NASDAQ:CXAI) reported fiscal Q2 2025 (period ended June 30, 2025) earnings on August 11, 2025, highlighting flat revenue of $1.22 million, gross margin improved to 86%, and significant
Is Occidental Petroleum a Buy on the Dip?
The name Occidental Petroleum (NYSE: OXY) gets more attention than it used to, thanks to the involvement of Warren Buffett and Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B), the company Buffett
Despite Lower Crude Prices, These Top Oil Stocks See Massive Free Cash Flow Gushers Ahead
Crude oil prices have declined this year. Brent, the global benchmark, has fallen by more than 15%, dropping from the low $80s to the mid-$60s. This decline hurt the cash flows of most oil
MeridianLink Revenue Jumps 8 Percent
MeridianLink (NYSE:MLNK), a provider of cloud-based software for banks, credit unions, and mortgage lenders, released its second quarter 2025 financial results on August 11, 2025. The company
Ceva Beats Estimates in Fiscal Q2
Ceva (NASDAQ:CEVA), a core supplier of chip design intellectual property (IP) for wireless connectivity and edge artificial intelligence (AI), reported its second quarter 2025 results on August 11
Motorcar Parts Q1 Revenue Up 11 Percent
Motorcar Parts Of America (NASDAQ:MPAA), a supplier of replacement parts and electrical diagnostic equipment for vehicles, reported its earnings for the fiscal first quarter (ended June 30, 2025) on
Aaon Posts 65 Percent EPS Drop in Q2
Aaon (NASDAQ:AAON), a leading manufacturer of heating, ventilation, and air conditioning (HVAC) equipment, reported earnings for Q2 2025 on August 11, 2025. The results highlighted operational
Village Farms Sales Jump 12 Percent
Village Farms International (NASDAQ:VFF), a diversified greenhouse grower and international cannabis producer, reported GAAP results for Q2 2025 on August 11, 2025. The company posted GAAP earnings
Kymera Revenue Drops 55 Percent in Q2
Kymera Therapeutics (NASDAQ:KYMR), a biotechnology company recognized for its targeted protein degradation technology, released its second quarter 2025 results on August 11, 2025. The most notable
Intermex Posts Mixed Results in Q2
International Money Express (NASDAQ:IMXI), a leading provider of money transfer services primarily between the United States and Latin America, reported results for Q2 2025 on August 11, 2025. The
Compass Therapeutics Posts Wider Q2 Loss
Compass Therapeutics (NASDAQ:CMPX), a clinical-stage biotechnology company focused on developing novel bispecific antibody therapies for cancer, released its second quarter results on August 11
Owens and Minor Misses Fiscal Q2 Targets
Owens & Minor (NYSE:OMI), a leading health care logistics and home health product distribution provider, reported its second quarter 2025 earnings on August 11, 2025. The most notable news was the
This Top Warren Buffett Stock Continues to Deliver an Impressive Performance
Warren Buffett's company, Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B), continues to be a big believer in Occidental Petroleum (NYSE: OXY). It's easy to see why when looking at the oil giant's
Why Palantir Stock Soared 21.2% This Week
Shares of Palantir (NASDAQ: PLTR) spiked this week, finishing up 21.2% from last Friday's close. The jump comes as the S&P 500 gained 2.4% and the Nasdaq-100 rose 3.7%. Palantir reported huge
This Oil Stock Is Now On Track to Produce an Extra $7 Billion in Surplus Cash by 2029
ConocoPhillips (NYSE: COP) is already a cash-gushing machine. The oil and gas giant's low-cost operations enable it to produce significant free cash flow. This allows it to invest in growing its
Plains GP Touts Asset Sale in Q2 Results
Plains GP Holdings(NASDAQ:PAGP) reported second-quarter 2025 adjusted EBITDA of $672 million and announced a $3.75 billion divestiture of its NGL business to Keyera, with closing expected in 2026